Abstract
Levetiracetam belongs to a group of new antiepileptic drugs with a complex mechanism of action. Introduced to the pharmaceutical market in the 1980s, to date it has established its position of an effective and a safe drug. This is supported by the predictable pharmacokinetics of the drug, the lack of drug interactions of clinical significance, the low risk of drug resistance as well as the lack of depressant effect on the central nervous system.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
